Ross Banerjee, Registered Massage Therapist

05/11/2025

For the first time in 30 years, I’ve had to do nothing for days and days. Recovering from surgery takes time and is remarkably painful. Still, the garden grows and weeds proliferate.

08/31/2023

Super moon

06/22/2023

Longest question…

06/08/2023

Smoke plumes in the setting sun sky.

05/16/2023

Flowers on my walk today. Reservoir Park and my house.

05/08/2023

Aerated my lawn today. Ok, yeah. I’m a cheapskate. I don’t like spending money. Got 5000 steps in, though. 🤪

05/08/2023

… e’s got big gnashing teeth …

04/18/2023

The final remnants of one of the two European Linden trees my father planted back in the 70s. I think it had a good life. It was cut short, much as my father’s life was cut short, by untimely damage caused by fire. In my father’s case, it was smoking. In this tree’s case, it was likely wind. Wind, of course, occurs when the air is heated by the sun, among other reasons… it’s a stretch, I know.

02/14/2023

I’ve been using Noterro for the last year or so. I will NEVER return to paper!! Check them out!

Ready to try Noterro? Signup and try our practice management software.

07/26/2022

07/26/2022

I’m hiding…

04/28/2022

(Reuters) — Canada on Thursday authorized British drugmaker AstraZeneca Plc's antibody-based therapy for preventing COVID-19 infections, giving itself another weapon against the disease as cases rise in the country.
Health Canada has cleared the drug — Evusheld — for use in individuals aged 12 years and older who are immune compromised and unlikely to mount an adequate immune response to COVID-19 vaccination or for whom COVID-19 vaccination is not recommended.
While vaccines rely on an intact immune system to develop targeted antibodies and infection-fighting cells, Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.
The therapy has already been authorized in the United States and its use has also been recommended by the European Medicines Agency.